CClinicalTrials.gg
WithdrawnNCT02398942Updated Dec 22, 2016

Proximal Pole Fractures of the Scaphoid

An observational study in Proximal Pole Fractures of the Scaphoid, sponsored by Massachusetts General Hospital. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-12-22.

Sponsored by Massachusetts General Hospital · Observational

Why this study was withdrawn
The investigator left the institution so the study was terminated.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
18 Years and older
Sex
All
01

Study summary

Aim:

The aim of this study is to analyze the clinical and radiological outcomes of patients with a proximal pole fracture of the scaphoid

Primary null hypothesis:

There are no factors associated with nonunion of a proximal pole fracture of the scaphoid.

Secondary null hypothesis:

Patients with an acute proximal pole fracture of the scaphoid have QuickDASH (Disabilities of the Arm, Shoulder, and Hand) scores at or above the population norm (a score of 13 in the Norway and 10.9 in the United States), 2 to 6 months after injury.

02

Conditions studied

  • Proximal Pole Fractures of the Scaphoid

Browse trials for

03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

Browse Fractures, Bone studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with proximal pole fracture of the scaphoid

Inclusion criteria

  • Age 18 years or greater
  • Proximal pole fracture of the scaphoid on computed tomography scans made in the planes defined by the long axis of the scaphoid. The proximal pole will be defined as the proximal fifth of the scaphoid, excluding small scapholunate ligament avulsion fractures.
  • Interval between injury and diagnosis of less than 2 weeks.
  • English or Spanish fluency and literacy

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • Inability to complete enrollment forms due to any mental status or language problems (e.g. dementia, head injury, overall illness).
  • Patients with other fractures or injuries
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Proximal Pole Fracture of the Scaphoid

    QuickDASH 6 months after injury CT scan 6 months after injury

06

What researchers measure

Primary outcomes

  1. Disability measured using QuickDASH

    Time frame: 6 months

  2. Nonunion of Fracture

    The nonunion of the fracture will be measured using CT imaging

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02398942
Lead sponsor
Massachusetts General Hospital
Collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Medical Center Haaglanden, The Hague, The Netherlands, Skane University Hospital, Ghaem Hospital
Responsible party
David C. Ring, MD (Chief of Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital) — Principal investigator
First posted
Mar 26, 2015
Start date
Mar 2015
Primary completion
Jan 2016
Completion
Jan 2016
Last update
Dec 22, 2016

Study contacts

David Ring, MD PhD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion